I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The Central Information Commission (CIC) has allowed woman access to generic details of her estranged husband's income in case of maintenance proceedings against him. The CIC has directed the Income ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for at least a ...
Canadian employers and their employees can expect to see drug plan savings as generic versions of diabetes and obesity medications are introduced, cutting insurance costs. Ozempic and Wegovy – two ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For the first time, a generic GLP-1 has been approved by ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...